Vita Life Sciences Dividends and Buybacks
Dividend criteria checks 5/6
Vita Life Sciences is a dividend paying company with a current yield of 5.65% that is well covered by earnings.
Key information
5.6%
Dividend yield
1.7%
Buyback Yield
| Total Shareholder Yield | 7.3% |
| Future Dividend Yield | n/a |
| Dividend Growth | 13.7% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | 75% |
Recent dividend and buyback updates
Recent updates
Vita Life Sciences (ASX:VLS) Is Due To Pay A Dividend Of A$0.045
Vita Life Sciences Limited ( ASX:VLS ) has announced that it will pay a dividend of A$0.045 per share on the 3rd of...Weekly Picks: 💊 VLS' Solvable Headwinds, VOS' Multi-Year Growth, and ISRG's Valuation Concerns
Why Vita Life Science’s is a solid business with solvable headwinds, how 2 massive tailwinds will drive multi-year growth for Vossloh, and why Intuitive Surgical’s strengths don’t outweigh the valuation risks.
Vita Life Sciences Set for a 12.72% Revenue Growth While Tackling Operational Challenges
Vita Life Sciences (ASX: VLS) – A Solid Business Seeking Renewed MomentumVita Life Sciences (ASX: VLS) is a well-established healthcare company specializing in the formulation, packaging, distributionImproved Earnings Required Before Vita Life Sciences Limited (ASX:VLS) Shares Find Their Feet
When close to half the companies in Australia have price-to-earnings ratios (or "P/E's") above 20x, you may consider...Vita Life Sciences Limited (ASX:VLS) Looks Inexpensive But Perhaps Not Attractive Enough
Vita Life Sciences Limited's ( ASX:VLS ) price-to-earnings (or "P/E") ratio of 14.3x might make it look like a buy...Vita Life Sciences (ASX:VLS) Has Announced A Dividend Of A$0.035
Vita Life Sciences Limited ( ASX:VLS ) has announced that it will pay a dividend of A$0.035 per share on the 4th of...Vita Life Sciences Limited (ASX:VLS) Stock Catapults 26% Though Its Price And Business Still Lag The Market
Vita Life Sciences Limited ( ASX:VLS ) shares have continued their recent momentum with a 26% gain in the last month...Vita Life Sciences (ASX:VLS) Has Announced That It Will Be Increasing Its Dividend To A$0.06
Vita Life Sciences Limited ( ASX:VLS ) will increase its dividend from last year's comparable payment on the 12th of...Vita Life Sciences' (ASX:VLS) Shareholders Will Receive A Bigger Dividend Than Last Year
The board of Vita Life Sciences Limited ( ASX:VLS ) has announced that the dividend on 12th of April will be increased...A Look At The Fair Value Of Vita Life Sciences Limited (ASX:VLS)
Today we will run through one way of estimating the intrinsic value of Vita Life Sciences Limited ( ASX:VLS ) by...Should You Be Adding Vita Life Sciences (ASX:VLS) To Your Watchlist Today?
Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...If You Like EPS Growth Then Check Out Vita Life Sciences (ASX:VLS) Before It's Too Late
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...Did Vita Life Sciences' (ASX:VLS) Share Price Deserve to Gain 83%?
The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...Vita Life Sciences Limited (ASX:VLS) On An Uptrend: Could Fundamentals Be Driving The Stock?
Vita Life Sciences' (ASX:VLS) stock up by 8.5% over the past three months. Given that stock prices are usually aligned...Vita Life Sciences (ASX:VLS) Is Growing Earnings But Are They A Good Guide?
Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. That said, the...Here's Why We Think Vita Life Sciences (ASX:VLS) Is Well Worth Watching
Like a puppy chasing its tail, some new investors often chase 'the next big thing', even if that means buying 'story...Vita Life Sciences Limited's (ASX:VLS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
With its stock down 8.3% over the past month, it is easy to disregard Vita Life Sciences (ASX:VLS). But if you pay...Vita Life Sciences Limited's (ASX:VLS) Prospects Need A Boost To Lift Shares
With a price-to-earnings (or "P/E") ratio of 9.7x Vita Life Sciences Limited (ASX:VLS) may be sending bullish signals...Stability and Growth of Payments
Fetching dividends data
Stable Dividend: VLS's dividends per share have been stable in the past 10 years.
Growing Dividend: VLS's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Vita Life Sciences Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (VLS) | 5.6% |
| Market Bottom 25% (AU) | 2.6% |
| Market Top 25% (AU) | 6.6% |
| Industry Average (Pharmaceuticals) | 2.2% |
| Analyst forecast (VLS) (up to 3 years) | n/a |
Notable Dividend: VLS's dividend (5.65%) is higher than the bottom 25% of dividend payers in the Australian market (2.6%).
High Dividend: VLS's dividend (5.65%) is low compared to the top 25% of dividend payers in the Australian market (6.64%).
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (75.1%), VLS's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (48%), VLS's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/08/04 20:22 |
| End of Day Share Price | 2026/08/04 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vita Life Sciences Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shane Storey | Canaccord Genuity Historic (Wilsons Advisory and Stockbroking Ltd. |